Since the combination of metformin with L-asparaginase induces massive DLBCL cell apoptosis and disrupts various pro-survival metabolic pathways, including glutamine metabolism, lipid metabolism, and mitochondrial activity, we next investigated how these two antimetabolic drugs impact critical oncogenic pathways involved in the metabolic stress response and cell survival. Here, ASPG is linked to diffuse large B-cell lymphoma.